The Supreme Court is set to hear arguments over glyphosate, the active ingredient in the widely used herbicide Roundup, reigniting a heated debate over the chemical's potential cancer risks and its regulatory status in the United States.
The case arrives as Robert F. Kennedy Jr., a longtime critic of Monsanto and advocate for those claiming non-Hodgkin lymphoma from glyphosate exposure, faces scrutiny over shifting positions on the matter. Critics note that Kennedy built his reputation on challenging Monsanto in court, yet recent statements have raised questions about his commitment to restricting the herbicide.
Glyphosate is used heavily by American farmers, and the primary domestic supplier is Monsanto, now owned by Germany's Bayer AG. While international agencies and U.S. regulators have not imposed bans, some studies have linked the chemical to cancer, fueling lawsuits and public concern.
The Supreme Court's decision could reshape liability for pesticide manufacturers and influence future regulations. For now, the case highlights the tension between agricultural reliance on glyphosate and growing calls for stricter safety measures.